Volume 22 Issue 9
Sep.  2024
Turn off MathJax
Article Contents
Article Navigation >  Chinese Journal of General Practice  > 2024  >  22(9): 1555-1558
SHANG Hong, SHAO Lei, HU Chongwei. Changes in inflammatory factors in children with allergic rhinitis before and after allergen-specific immunotherapy: expression spectrum and clinical significance[J]. Chinese Journal of General Practice, 2024, 22(9): 1555-1558. doi: 10.16766/j.cnki.issn.1674-4152.003681
Citation: SHANG Hong, SHAO Lei, HU Chongwei. Changes in inflammatory factors in children with allergic rhinitis before and after allergen-specific immunotherapy: expression spectrum and clinical significance[J]. Chinese Journal of General Practice, 2024, 22(9): 1555-1558. doi: 10.16766/j.cnki.issn.1674-4152.003681
shu

Changes in inflammatory factors in children with allergic rhinitis before and after allergen-specific immunotherapy: expression spectrum and clinical significance

doi: 10.16766/j.cnki.issn.1674-4152.003681

  • Department of Pediatrics, Chun'an Branch of Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang 311700, China

Funds:

 2023XY014

  • Received Date: 2024-01-02
    Abstract
  •   Objective  To detect the expression levels of inflammatory factors in children with allergic rhinitis before and after subcutaneous specific immunotherapy (SCIT) and to analyze the application value of these inflammatory factors in evaluating the efficacy of SCIT.  Methods  Eighty children with allergic rhinitis (AR) who received standard SCIT at the pediatric department of Chun'an Branch of Zhejiang Provincial People's Hospital from February 2021 to July 2023 were divided into a response group (n=48) and a non-response group (n=32) according to the curative effect. The baseline levels of inflammatory factors were compared between the two groups. The variables with P < 0.05 were selected for univariate logistic regression model, and the ROC curves were drawn to analyze the predictive effect of SCIT on AR children.  Results  After treatment, the levels of C-reactive protein (CRP), interleukin (IL)-1β, IL-6, and IL-13 decreased, while the levels of tumor necrosis factor-β (TNF-β), IL-10, and IL-33 increased (P < 0.05).The baseline levels of IL-10 and IL-33 in children in the response group were lower than those in the non-response group (P < 0.05). Univariate logistic regression analysis showed that IL-10 (OR=0.344) and IL-33 (OR=0.963) significantly affected SCIT outcomes (P < 0.05). ROC curve showed that IL-10 (AUC=0.836) and IL-33 (AUC=0.833) have good predictive value for SCIT efficacy.  Conclusion  After SCIT treatment, the levels of TNF-β, IL-10, and IL-33 increased, while the levels of CRP, IL-1β, IL-6, and IL-13 decreased. Baseline levels of IL-10 and IL-33 are valuable predictors of efficacy.

     

    • FullText(HTML)
  • loading
    • References(25)
  • [1]
    RAPIEJKO P, JURKIEWICZ D, PIETRUSZEWSKA W, et al. Treatment strategy of allergic rhinitis in the face of modern world threats[J]. Otolaryngol Pol, 2018, 72(2): 1-12. doi: 10.5604/01.3001.0011.8057
    [2]
    SCHULER Ⅳ C F, MONTEJO J M. Allergic rhinitis in children and adolescents[J]. Immunol Allergy Clin North Am, 2021, 41(4): 613-625. doi: 10.1016/j.iac.2021.07.010
    [3]
    PAPADOPOULOS N G, AGGELIDES X, STAMATAKI S, et al. New concepts in pediatric rhinitis[J]. Pediatr Allergy Immunol, 2021, 32(4): 635-646. doi: 10.1111/pai.13454
    [4]
    SULTÉSZ M, HORVÁTH A, MOLNÁR D, et al. Prevalence of allergic rhinitis, related comorbidities and risk factors in schoolchildren[J]. Allergy Asthma Clin Immunol, 2020, 16(1): 98. DOI: 10.1186/s13223-020-00495-1.
    [5]
    OKUBO K, KURONO Y, ICHIMURA K, et al. Japanese guidelines for allergic rhinitis 2020[J]. Allergol Int, 2020, 69(3): 331-345. doi: 10.1016/j.alit.2020.04.001
    [6]
    LI H B, CHEN S, CHENG L, et al. Chinese guideline on sublingual immunotherapy for allergic rhinitis and asthma[J]. J Thorac Dis, 2019, 11(12): 4936-4950. doi: 10.21037/jtd.2019.12.37
    [7]
    LIU Z, LU H, FENG X, et al. Predictive methods for efficacy of house dust mite subcutaneous immunotherapy in allergic rhinitis patients: a prospective study in a Chinese population[J]. Int Forum Allergy Rhinol, 2020, 10(3): 314-319. doi: 10.1002/alr.22508
    [8]
    LICARI A, CASTAGNOLI R, BRAMBILLA I, et al. Biomarkers of immunotherapy response in patients with allergic rhinitis[J]. Expert Rev Clin Immunol, 2018, 14(8): 657-663. doi: 10.1080/1744666X.2018.1504679
    [9]
    KIM J Y, RHEE C S, MUN S J, et al. Early response of specific IgE can predict satisfaction with sublingual immunotherapy[J]. Laryngoscope, 2021, 131(3): 467-472. doi: 10.1002/lary.28762
    [10]
    XIE S B, ZHANG H, WANG F J, et al. Circulating MIF associated with disease severity and clinical response of sublingual immunotherapy in house dust mite-induced allergic rhinitis[J]. Front Pharmacol, 2021, 12(1): 681724. DOI: 10.3389/fphar.2021.681724.
    [11]
    JOUDI M, FARID HOSSEINI R, KHOSHKHUI M, et al. Effects of serum vitamin D and efficacy of subcutaneous immunotherapy in adult patients with allergic rhinitis[J]. Allergy Asthma Immunol Res, 2019, 11(6): 885-893. doi: 10.4168/aair.2019.11.6.885
    [12]
    付晴, 米光熙, 李建涛, 等. 变应性鼻炎的诊治进展[J]. 牡丹江医学院学报, 2018, 39(1): 119-122.

    FU Q, MI G X, LI J T, et al. Progress in diagnosis and treatment of allergic rhinitis[J]. Journal of Mudanjiang Medical University, 2018, 39(1): 119-122.
    [13]
    XIE S, JIANG S, ZHANG H, et al. Prediction of sublingual immunotherapy efficacy in allergic rhinitis by serum metabolomics analysis[J]. Int Immunopharmacol, 2021, 90(1): 107211. DOI: 10.1016/j.intimp.2020.107211.
    [14]
    XIE S, ZHANG H, WANG F, et al. Activated leukocyte cell adhesion molecule as a biomarker for disease severity and efficacy of sublingual immunotherapy in allergic rhinitis[J]. Int Immunopharmacol, 2020, 88(1): 106975. DOI: 10.1016/j.intimp.2020.106975.
    [15]
    田亮, 张伟. 白三烯受体拮抗剂对过敏性鼻炎模型大鼠血清IL-6、IL-10及TNF-α表达的影响[J]. 河北医药, 2019, 41(19): 2889-2893. doi: 10.3969/j.issn.1002-7386.2019.19.002

    TIAN L, ZHANG W. Effects of leukotriene receptor antagonists on the expressions of IL-6, IL-10 and TNF-α in serum of rats with allergic rhinitis[J]. Hebei Medical Journal, 2019, 41(19): 2889-2893. doi: 10.3969/j.issn.1002-7386.2019.19.002
    [16]
    尤宏银. 过敏性鼻炎患者血清中Treg细胞含量及炎症因子水平与患者病情的关系[J]. 中国卫生检验杂志, 2017, 27(6): 845-847.

    YOU H Y. The relationship between serum levels of Treg cells and inflammatory factors in patients with allergic rhinitis and severity[J]. Chinese Journal of Health Laboratory Technology, 2017, 27(6): 845-847.
    [17]
    刘宇萌, 安东. 淋巴细胞亚群检测在肾病综合征患儿免疫功能评价中的意义[J]. 中华全科医学, 2022, 20(4): 661-664, 672. doi: 10.16766/j.cnki.issn.1674-4152.002424

    LIU Y M, AN D. Significance of lymphocyte subset detection in immune function evaluation of children with nephrotic syndrome[J]. Chinese Journal of General Practice, 2022, 20(4): 661-664, 672. doi: 10.16766/j.cnki.issn.1674-4152.002424
    [18]
    ERKAN K, BOZKURT M K, ARTAÇ H, et al. The role of regulatory T cells in allergic rhinitis and their correlation with IL-10, IL-17 and neopterin levels in serum and nasal lavage fluid[J]. Eur Arch Otorhinolaryngol, 2020, 277(4): 1109-1114. doi: 10.1007/s00405-020-05811-4
    [19]
    ZISSLER U M, JAKWERTH C A, GUERTH F M, et al. Early IL-10 producing B-cells and coinciding Th/Tr17 shifts during three year grass-pollen AIT[J]. EBioMedicine, 2018, 36(1): 475-488.
    [20]
    EL-MAGHRABY H M, RABIE R A. Serum level of IL-10 is significantly increased in allergic rhinitis patients on subcutaneous immunotherapy and vitamin D supplementation[J]. Egypt J Immunol, 2019, 26(2): 87-93.
    [21]
    SHARIF H, ACHARYA S, DHONDALAY G, et al. Altered chromatin landscape in circulating T follicular helper and regulatory cells following grass pollen subcutaneous and sublingual immunotherapy[J]. J Allergy Clin Immunol, 2021, 147(2): 663-676. doi: 10.1016/j.jaci.2020.10.035
    [22]
    POINTNER L, BETHANIS A, THALER M, et al. Initiating pollen sensitization -complex source, complex mechanisms[J]. Clin Transl Allergy, 2020, 10(1): 36. doi: 10.1186/s13601-020-00341-y
    [23]
    HACCURIA A, VAN MUYLEM A, MALINOVSCHI A, et al. Increased expression of IL-33 is found in the lower airways of patients with seasonal allergic rhinitis and is not related to natural allergen exposure[J]. Clin Exp Allergy, 2021, 51(6): 845-848. doi: 10.1111/cea.13819
    [24]
    WANG Y M, LI C L, XU Y X, et al. Sublingual immunotherapy decreases expression of interleukin-33 in children with allergic rhinitis[J]. Indian J Pediatr, 2018, 85(10): 872-876. doi: 10.1007/s12098-018-2703-3
    [25]
    GLÜCK J, RYMARCZYK B, JURA-SZOŁTYS E, et al. Serum levels of interleukin 33 and its receptor ST2 in patients treated with subcutaneous allergen immunotherapy in intermittent allergic rhinitis[J]. Cent Eur J Immunol, 2019, 44(2): 214-217. doi: 10.5114/ceji.2019.87075
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(5)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (20) PDF downloads(2) Cited by()
    Proportional views
    Related

    Address：No. 287, Changhuai Road, Bengbu, Anhui Province, 233004, P.R.ChinaphoneNo：0552-3066635； 0552-3051890Email：zhqkyx@163.com

    Copyright © Chinese Journal of General Practice皖ICP备2020018345号-2

    Supported by: Beijing Renhe Information Technology Co., Ltd.    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return